Related Experiment Video
Updated: May 22, 2025
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
A deep dive into four thyroglobulin immunoassays from analytical perspective.
Tuba Saadet Deveci Bulut1, Muhittin Abdulkadir Serdar2, Mehmet Muhittin Yalçın3
1Department of Medical Biochemistry, Gazi University School of Medicine, Ankara, Turkey.
Second-generation serum thyroglobulin assays offer reliable monitoring for differentiated thyroid cancer (DTC), unlike older methods affected by autoantibodies. These advanced tests ensure consistent, sensitive detection for better patient outcomes.
Area of Science:
- Clinical Chemistry
- Oncology Diagnostics
- Immunoassay Technology
Background:
- Serum thyroglobulin immunometric assays (sTg) are essential for monitoring differentiated thyroid cancer (DTC) treatment.
- Challenges like anti-thyroglobulin autoantibodies (TgAb) and assay variability can impact the accuracy of sTg measurements.
- Evaluating different sTg assay generations is crucial for optimizing DTC patient management.
Purpose of the Study:
- To assess the performance of three second-generation sTg assays (Architect, Access, Elecsys) and one first-generation assay (Immulite).
- To compare assay precision, sensitivity, and agreement according to CLSI and ATA guidelines.
- To evaluate the impact of TgAb on assay performance.
Main Methods:
- Compared four sTg assays: Architect, Access, Elecsys (second-generation), and Immulite (first-generation).
- Evaluated precision (CLSI EP05-A3), lower limits of detection (CLSI EP17-A2), and assay agreement (CLSI EP09c, Kappa statistics).
- Analyzed assay performance across different concentration ranges and in the presence of TgAb.
Main Results:
- Second-generation assays (Architect, Access, Elecsys) demonstrated satisfactory precision (<7% CV) and strong correlations (r > 0.884) across concentrations.
- The Immulite assay showed inadequate sensitivity (LoQ = 4.59 μg/L), significant deviations, and poorer correlation (<10 μg/L) with second-generation assays.
- TgAb significantly interfered with the Immulite assay, leading to lower concordance (κ: 0.562-0.653) compared to second-generation assays (κ > 0.800).
Conclusions:
- The Immulite assay failed to meet LLD and precision criteria for DTC monitoring due to TgAb interference and inadequate sensitivity.
- Second-generation sTg assays (Architect, Access, Elecsys) provide consistent and reliable performance for DTC monitoring across various concentrations.
- Clinicians should consider the generation and potential TgAb interference when selecting sTg assays for differentiated thyroid cancer management.
More Related Videos
06:15Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
05:19Author Spotlight: Advancing Protein Glycosylation Research Using a Fully Automated System
Published on: June 28, 2024
